nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A multicenter, randomized phase 2 study to establish combinations of CBP501, cisplatin and nivolumab for ≥3rd-line treatment of patients with advanced pancreatic adenocarcinoma
|
Enzler, T. |
|
|
201 |
C |
p. |
artikel |
2 |
An audit of 1632 routinely collected cervical cancer screening smears from 398 women in Germany: Results from the TeQaZ Study
|
Tanaka, Luana F. |
|
|
201 |
C |
p. |
artikel |
3 |
Carcinomas of the external auditory canal: Management and results: A multicenter REFCOR propensity score matching study
|
Brenet, Esteban |
|
|
201 |
C |
p. |
artikel |
4 |
Clinical trial inclusion in patients with relapsed/refractory neuroblastoma following the European Precision Cancer Medicine trial MAPPYACTS
|
Chaix, Jordane |
|
|
201 |
C |
p. |
artikel |
5 |
Corrigendum to “Despite multi-disciplinary team discussions the socioeconomic disparities persist in the oncological treatment of non-metastasized colorectal cancer” [Eur J Cancer 199 (2024) 113572]
|
Osterman, Erik |
|
|
201 |
C |
p. |
artikel |
6 |
Corrigendum to “Risk factors for early-onset pancreatic ductal adenocarcinoma: A systematic literature review” [Eur J Cancer 198 (2024) 113471]
|
Chandana, Sreenivasa R. |
|
|
201 |
C |
p. |
artikel |
7 |
Differentiation of survival outcomes by anatomic involvement and histology with the revised 2023 International Federation of Gynecology and Obstetrics staging system for endometrial cancer
|
Gravbrot, Nicholas |
|
|
201 |
C |
p. |
artikel |
8 |
Editorial Board
|
|
|
|
201 |
C |
p. |
artikel |
9 |
Effectiveness and safety of COVID-19 vaccination in people with blood cancer
|
Copland, Emma |
|
|
201 |
C |
p. |
artikel |
10 |
Equal censoring but still informative: When the reasons for censoring differ between treatment arms
|
Olivier, Timothée |
|
|
201 |
C |
p. |
artikel |
11 |
Evaluating regulatory consistency for international anti-PD-(L)1 clinical trials
|
Wu, Albert Q. |
|
|
201 |
C |
p. |
artikel |
12 |
Evolution of HER2 expression between pre-treatment biopsy and residual disease after neoadjuvant therapy for breast cancer
|
Tarantino, Paolo |
|
|
201 |
C |
p. |
artikel |
13 |
Gemcitabine and nab-paclitaxel combined with afatinib in metastatic pancreatic cancer – Results of a phase 1b clinical trial
|
Zhang, Danmei |
|
|
201 |
C |
p. |
artikel |
14 |
Impact of central nervous system metastasis after complete resection of lung adenocarcinomas harboring common EGFR mutation – A real-world database study in Japan: The CReGYT-01 EGFR study
|
Katsumata, Shinya |
|
|
201 |
C |
p. |
artikel |
15 |
Isolated melanoma cells in sentinel lymph node in stage IIIA melanoma correlate with a favorable prognosis similar to stage IB
|
Amaral, Teresa |
|
|
201 |
C |
p. |
artikel |
16 |
Letter re: Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study
|
Laganà, Marta |
|
|
201 |
C |
p. |
artikel |
17 |
Molecular Tumor Boards: On the evolution of species
|
Giacomini, Patrizio |
|
|
201 |
C |
p. |
artikel |
18 |
Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer
|
Arai, Hiroyuki |
|
|
201 |
C |
p. |
artikel |
19 |
Prognostic and predictive value of non-steroidal anti-inflammatory drugs in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma
|
Kennedy, Oliver John |
|
|
201 |
C |
p. |
artikel |
20 |
Real-world data on malignant and borderline phyllodes tumors of the breast: A population-based study of all 921 cases in the Netherlands (1989 −2020)
|
Bartels, Sanne A.L. |
|
|
201 |
C |
p. |
artikel |
21 |
Real-world treatment patterns and outcomes for patients with multiple myeloma in Denmark, Finland and Sweden: An analysis using linked Nordic registries
|
Abildgaard, Niels |
|
|
201 |
C |
p. |
artikel |
22 |
Reconciling the discrepancies in randomized data of combining immunotherapy and radiation therapy: Not all radiotherapy is created equal
|
Chang, Joe Y. |
|
|
201 |
C |
p. |
artikel |
23 |
Safety and efficacy of nivolumab in elderly patients with metastatic clear cell renal cell carcinoma: Analysis of the NIVOREN GETUG-AFU 26 study
|
Mourey, Loïc |
|
|
201 |
C |
p. |
artikel |
24 |
Sotorasib in KRAS G12C-mutated non-small cell lung cancer: A multicenter real-world experience from the compassionate use program in Germany
|
Stratmann, Jan A. |
|
|
201 |
C |
p. |
artikel |
25 |
TLD-1, a novel liposomal doxorubicin, in patients with advanced solid tumors: Dose escalation and expansion part of a multicenter open-label phase I trial (SAKK 65/16)
|
Colombo, Ilaria |
|
|
201 |
C |
p. |
artikel |